Early Release of New Book: Anonymizing Health Data
Anonymizing Health Data
Authors: Khaled El Emam, PhD and Luk Arbuckle
Clinical and research organizations increasingly want to share patient data, and robust de-identification is crucial to meet legal obligations and or ethical reasons. This book, written by two leading experts in de-identification, explains how to adhere to regulations in a defensible way to protect sensitive patient data. Numerous case studies are included from settings that range from typical clinical treatment to disease registries.
The metrics used to determine that re-identification is unlikely, and special cases such as continuously released data, will be covered. The authors finish with a discussion of the effects of de-identification on data quality and analysis.
As an early release book from O’Reilly Media, you are getting access to Anonymizing Health Data in its earliest form – raw and unedited content as we write which provides you to access to the methodologies and technology before the official release. You’ll also get access to updates when we make significant changes, add new chapters, as well as the final e-book bundle.
Publisher: O’Reilly Media
- Turn Data Assets into Business Opportunity Under CCPADecember 19, 2019
- How does risk-based anonymization work?December 18, 2019
- Why should I use Expert Determination over Safe Harbor?December 18, 2019
- What do I need to know about GDPR, HIPAA and CCPA to meet our regulatory and privacy obligations?December 18, 2019
- Should we invest in building our own de-identification capability?December 17, 2019
- GDPR and The Future of Clinical Trials Data SharingMarch 18, 2019
- Advancing Principled Data Practices in Support of Emerging TechnologiesMarch 15, 2019
- “Zero Risk Does Not Exist”February 7, 2019
- Is Anonymization Possible with Current Technologies?January 9, 2019
- Comparing the benefits of pseudonymisation and anonymisation under the GDPRDecember 20, 2018